Correlation for detection of TKI-sensitizing or T790M mutations of EGFR between plasma and either tumor tissue or malignant fluid (rebiopsy) specimens obtained after the development of EGFR-TKI resistance (n = 41). The gene discussed is EGFR; the disease is neoplasm.